Christine Årdal
Norwegian Institute of Public Health(NO)
Publications by Year
Research Areas
Antibiotic Use and Resistance, Pharmaceutical Economics and Policy, Antibiotic Resistance in Bacteria, Biosimilars and Bioanalytical Methods, Pharmaceutical and Antibiotic Environmental Impacts
Most-Cited Works
- → Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?(2013)470 cited
- → Antibiotic development — economic, regulatory and societal challenges(2019)432 cited
- → International cooperation to improve access to and sustain effectiveness of antimicrobials(2015)142 cited
- → Antibiotic research and development: business as usual?(2015)83 cited
- → Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020(2021)64 cited
- → Introduction and geographic availability of new antibiotics approved between 1999 and 2014(2018)63 cited
- → A one health framework to estimate the cost of antimicrobial resistance(2020)63 cited
- → Open Source Drug Discovery in Practice: A Case Study(2012)60 cited
- Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access(2018)
- → Industrial perceptions of medicines regulatory harmonization in the East African Community(2019)43 cited